Skip to site menu Skip to page content

Daily Newsletter

18 August 2023

Daily Newsletter

18 August 2023

Ambiki launches self-writing note system to document therapy sessions

Tenalog automatically generates notes by recording therapy sessions using Ambiki's HIPAA-compliant recorder.

August 18 2023

Speech Therapy EMR software-as-a-service (SaaS) application Ambiki has introduced Tenalog, a new self-writing note system aimed at transforming the way speech-language pathologists (SLPs) document their therapy sessions.

The Tenalog feature allows SLPs to focus entirely on their patients, rather than on administrative tasks.

It automatically generates notes by recording therapy sessions using Ambiki's HIPAA-compliant recorder.

It produces a transcript with timestamps and speaker labels, offers error analysis for patient utterances, and creates subjective, objective assessment and plan (SOAP) visit notes.

Tenalog also provides progress tracking, articulation charts, and additional features such as MVP Reels for showcasing patient progress.

It starts at $1 per session and helps enhance SLPs' efficiency and patient care.

Ambiki founder Kevin Dias said: “Our aim with Tenalog has always been to alleviate the administrative burden on SLPs and empower them to focus on why they became an SLP in the first place, helping their patients.

“Tenalog frees the therapist from the stress of mentally logging what is happening in a session for their note and instead dedicate their full attention to their patient and truly be present in the moment.”

Ambitious Idea Labs’ Ambiki platform is designed to simplify therapy processes for various healthcare professionals, including feeding, occupational, physical, and speech therapists.

The platform originated in 2019 as an internal electronic medical record (EMR) system and was publicly launched in January 2022, with various features, including therapy tools, teletherapy, and tools for showcasing therapists' expertise.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close